Omeclamox-Pak is an FDA-approved prescription drug that combines several drug therapies for treatment of Helicobacter pylori infection and duodenal ulcer disease.
Cumberland will promote the drug to its gastroenterologists, and Pernix will promote the produce to its primary care physicians.
More Articles on Gastroenterology:
gMed Announcces gInsights Business & Clinical Intelligence Platform
Stay Competitive: 5 Enhancements for GI/Endoscopy Groups
gGastro EHR System Receives Full EHR Certification
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
